MedPath

Efficacy of the topical Aluminum chloride 25/% gel in treatment of Epistaxis

Phase 3
Conditions
Epistaxis.
Epistaxis
Registration Number
IRCT20180129038549N6
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
118
Inclusion Criteria

Anterior Epistaxis

Exclusion Criteria

Trauma
Posterior epistaxis
History of bleeding disorders

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Epistaxis control. Timepoint: Every 5 minutes. Method of measurement: Physical exam.
Secondary Outcome Measures
NameTimeMethod
Time to stop nose bleeding. Timepoint: Up 30 minutes. Method of measurement: Physical exam.;Rebleeding. Timepoint: Up to 24 hours. Method of measurement: Physical exam.;Patient Satisfaction. Timepoint: Up to 30 minutes. Method of measurement: Questionnaire.
© Copyright 2025. All Rights Reserved by MedPath